Democratic VP Nominee Edwards Bolsters Kerry’s “Affordable Health Care” Agenda
This article was originally published in The Pink Sheet Daily
Executive Summary
Sen. Edwards is an advocate of stricter DTC regulation, generic patent law reform, comparative effectiveness research and DoJ investigation of manufacturer “price gouging.”
You may also be interested in...
Medicare Rx "Non-Interference" Provision Is Bipartisan Target, Former CMS Official Says
Statutory language prohibiting HHS from negotiating prices with drug manufacturers will likely be repealed in the next two years regardless of the presidential election's outcome, Patton Boggs partner Kathleen Means says.
“Fallback” Plan Will Be Main Medicare Rx Program, Medco Predicts
The private sector is unlikely to offer stand-alone drug insurance plans under Medicare in 2006, Medco CEO David Snow predicted during the Goldman Sachs conference in Laguna Niguel, Calif. June 9
DTC Ads Must Be "Clear And Balanced" Under Sen. Edwards Bill
The legislation is similar to an amendment Edwards proposed for the Medicare Rx bill. It also calls for NIH comparative efficacy studies and an expedited drug advertisement review process.